Clinical Trials | A randomized, double-blind, placebo-controlled study of intranasal oxytocin for bone health in children with autism spectrum disorder
A randomized, double-blind, placebo-controlled study of intranasal oxytocin for bone health in children with autism spectrum disorder
he Department of Pediatrics seeks children ages 6-18 years with a confirmed diagnosis of autism spectrum disorder (ASD) to participate in Bone Oxytocin (BOX) Study. The purpose of this study is to learn more about if children with autism are at risk for low bone density. Study participation includes 6 visits over a period of 18 months. Participants will be compensated $680 for completing all the study visits. It will also assess social and behavioral impacts from oxytocin nasal spray. The data we collect may be used to improve care and resources for future patients. For more information, please contact the study team at [email protected], or 434-982-0871.